Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study
Authors:
- Kazuhiro AsamiKAKazuhiro Asami
- Tomonobu KoizumiTKTomonobu Koizumi
- Kazuya HiraiKHKazuya Hirai
- Shingo AmeshimaSAShingo Ameshima
- Akihiro TsukadairaATAkihiro Tsukadaira
- Nobutoshi MorozumiNMNobutoshi Morozumi
- Akio MorikawaAMAkio Morikawa
- Shinji AtagiSAShinji Atagi
- Masaaki KawaharaMKMasaaki Kawahara
- 1 November 2011
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 12 (6) , 387-392
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Response Rate Is Associated with Prolonged Survival in Patients with Advanced Non-small Cell Lung Cancer Treated with Gefitinib or ErlotinibJournal of Thoracic Oncology, 2009
- Considerations for Second-Line Therapy of Non-Small Cell Lung CancerThe Oncologist, 2008
- A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutationsBritish Journal of Cancer, 2006
- Prospective Phase II Study of Gefitinib for Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene MutationsJournal of Clinical Oncology, 2006
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2005
- Elderly Patients with Advanced Non-Small Cell Lung CancerOncology, 2003
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer A multicenter phase II studyLung Cancer, 2000